(Q37156296)

English

High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies

scientific article published on January 2009

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

High-dose antipsychotic use in schizophrenia: a comparison between the 2001 and 2004 Research on East Asia Psychotropic Prescription (REAP) studies (English)

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

0 references

Gabor S Ungvari

6

object named as

Gabor Ungvari

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Norman Sartorius

14

object named as

Norman Sartorius

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Naotaka Shinfuku

11

object named as

Naotaka Shinfuku

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

author name string

Kang Sim

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Hsin Chuan Su

2

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Senta Fujii

3

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Shu-Yu Yang

4

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Mian-Yoon Chong

5

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Tianmei Si

7

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Yan Ling He

8

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Eun Kee Chung

9

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Yiong Huak Chan

10

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Ee Heok Kua

12

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Chay Hoon Tan

13

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

language of work or name

0 references

publication date

1 January 2009

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

British Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

67

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

110-117

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Variables associated with high olanzapine dosing in a state hospital.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Antipsychotic polypharmacy in patients with schizophrenia: a multicentre comparative study in East Asia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Reducing the dose of antipsychotic medications for those who had been treated with high-dose antipsychotic polypharmacy: an open study of dose reduction for chronic schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Chlorpromazine equivalent doses for the newer atypical antipsychotics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

The pharmacological treatment of schizophrenia in Chinese patients: a comparison of prescription patterns between 1996 and 1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Very high dose fluphenazine decanoate: a controlled trial in chronic schizophrenia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

6 September 2017

Excessive antipsychotic dosing in 2 U.S. State hospitals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

14 September 2017

Patients with schizophrenia at risk for excessive antipsychotic dosing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

27 June 2018

Medicine based evidence, a prerequisite for evidence based medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

27 June 2018

Factors associated with antipsychotic dosing in psychiatric inpatients: a prospective study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Increased risk of extrapyramidal side-effect treatment associated with atypical antipsychotic polytherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

High dose antipsychotic use in schizophrenia: findings of the REAP (research on east Asia psychotropic prescriptions) study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Multiple versus single antipsychotic agents for hospitalized psychiatric patients: case-control study of risks versus benefits.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Large doses of chlorpromazine in the treatment of psychiatric patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Antipsychotic prescribing practices in Connecticut's public mental health system: rates of changing medications and prescribing styles

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Delays in adopting evidence-based dosages of conventional antipsychotics.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

High-dose treatment with haloperidol: the effect of dose reduction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Pharmacoepidemiology of psychotropic drugs in patients with severe mental disorders in Italy. Italian Collaborative Study Group on the Outcome of Severe Mental Disorders.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Mortality in schizophrenia. Antipsychotic polypharmacy and absence of adjunctive anticholinergics over the course of a 10-year prospective study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: a double-blind PET study of schizophrenic patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

3 September 2018

Persistence with polypharmacy and excessive dosing in patients with schizophrenia treated in four European countries

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2668091

4 December 2018

Pharmaco-epidemiology in 136 hospitalized schizophrenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19133060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychotropic drug prescription in rehabilitation. A survey in Hong Kong

1 reference

https://pubmed.ncbi.nlm.nih.gov/19133060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for depot antipsychotic treatment in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19133060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Real-life dosing with second-generation antipsychotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/19133060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dosage of conventional neuroleptic medication and subjective cognitive functioning in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19133060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antipsychotic dosage at hospital discharge and outcomes among persons with schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19133060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prien RF, Cole JO: High dose chlorpromazine therapy in chronic schizophrenia. Report of National Institute of Mental Health--psychopharmacology research branch collaborative study group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19133060

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2125.2008.03304.X

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37156296&oldid=2113991907"